United States · FDA National Drug Code directory
NINLARO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63020-230_184bc16b-40f1-4fd3-a70b-17bbb44eac21
- Product NDC
- 63020-230
- Form
- CAPSULE
- Composition / generic term
- ixazomib
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20151120
- Source listing expiry
- 20271231
Source-listed ingredients
- IXAZOMIB CITRATE — 2.3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CAPSULE in 1 BLISTER PACK (63020-230-01) · 63020-230-01
- 1 BLISTER PACK in 1 CARTON (63020-230-02) / 3 CAPSULE in 1 BLISTER PACK (63020-230-03) · 63020-230-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →